Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $EWTX vs $MANE | Chartloom

Compare

$EWTX vs $MANE

Edgewise Therapeutics Inc · Veradermics Inc

EWTX

Edgewise Therapeutics Inc

MANE

Veradermics Inc

Compare $EWTX vs $MANE

Comparing Edgewise Therapeutics Inc and Veradermics Inc

EWTXEdgewise Therapeutics Inc

MANEVeradermics Inc

EWTXEdgewise Therapeutics Inc

Market cap

$3.90B

P/E (TTM)

—

Forward P/E (NTM)

19.86x

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

52.8%

52W performance

140.1%

FCF yield

-4.1%

MANEVeradermics Inc

Market cap

$4.86B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

208.0%

52W performance

208.0%

FCF yield

-2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EWTX

MANE

Detailed metrics comparison

EWTX

Edgewise Therapeutics Inc

MANE

Veradermics Inc

Market Cap

EWTX$3.90B

MANE$4.86B

Enterprise Value

EWTX$3.83B

MANE$4.54B

Price

EWTX$36.28

MANE$116.26

P/E Ratio

EWTXN/A

MANEN/A

P/S Ratio

EWTX0.00x

MANE0.00x

EV/Sales

EWTX0.00x

MANE0.00x

EV/EBITDA

EWTX0.00x

MANE0.00x

P/B Ratio

EWTX9.47x

MANE6.72x

P/FCF Ratio

EWTXN/A

MANEN/A

EV/FCF

EWTX-24.12x

MANE-42.29x

PEG Ratio

EWTXN/A

MANEN/A

Forward P/E (NTM)

EWTX19.86x

MANEN/A

Forward P/S (NTM)

EWTXN/A

MANEN/A

Revenue (TTM)

EWTX$0

MANE$0

Revenue Growth (YoY)

EWTXN/A

MANEN/A

Forward Rev Growth

EWTX0.0%

MANE308.7%

Gross Margin (TTM)

EWTX0.0%

MANE0.0%

Operating Margin (TTM)

EWTX0.0%

MANE0.0%

EBITDA Margin (TTM)

EWTX0.0%

MANE0.0%

Net Margin (TTM)

EWTX0.0%

MANE0.0%

FCF Margin (TTM)

EWTXN/A

MANEN/A

Net Income (TTM)

EWTX$-197M

MANE$-137M

FCF (TTM)

EWTX$-159M

MANE$-107M

EPS (TTM)

EWTX-$1.83

MANE-$3.39

ROE (TTM)

EWTX-3901.0%

MANE-3549.0%

ROA (TTM)

EWTX-3696.0%

MANE-3463.0%

ROIC (TTM)

EWTX-3901.0%

MANE-3549.0%

Cash

EWTX$72M

MANE$319M

Debt

EWTX$0

MANE$0

Net Cash/Debt

EWTX$72M

MANE$319M

Current Ratio (TTM)

EWTX16.24x

MANE70.53x

Quick Ratio (TTM)

EWTX16.01x

MANE70.35x

Debt/Equity (TTM)

EWTX0.00x

MANE0.00x

Debt/Assets (TTM)

EWTX0.0%

MANE0.0%

Interest Coverage (TTM)

EWTXN/A

MANEN/A

Net Debt/EBITDA (TTM)

EWTX0.00x

MANE0.00x

Beta

EWTX0.37

MANE-0.05

52W Performance

EWTX140.1%

MANE208.0%

YTD Performance

EWTX52.8%

MANE208.0%

% from 52W High

EWTX-25.2%

MANE-15.0%

% from 52W Low

EWTX154.6%

MANE263.3%

Asset Turnover (TTM)

EWTX0.00x

MANE0.00x

FCF Yield (TTM)

EWTX-4.1%

MANE-2.2%

Earnings Yield (TTM)

EWTX-5.1%

MANE-2.8%

Dividend Yield (TTM)

EWTXN/A

MANEN/A

Rule of 40

EWTX0.0

MANE0.0

EV/GP/RG

EWTXN/A

MANEN/A

Ticker research

View EWTX research View MANE research

Metric	EWTX Edgewise Therapeutics Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$3.90B	$4.86B
Enterprise Value	$3.83B	$4.54B
Price	$36.28	$116.26
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	9.47x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-24.12x	-42.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	19.86x	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	308.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-197M	$-137M
FCF (TTM)	$-159M	$-107M
EPS (TTM)	-$1.83	-$3.39
ROE (TTM)	-3901.0%	-3549.0%
ROA (TTM)	-3696.0%	-3463.0%
ROIC (TTM)	-3901.0%	-3549.0%
Financial Health
Cash	$72M	$319M
Debt	$0	$0
Net Cash/Debt	$72M	$319M
Current Ratio (TTM)	16.24x	70.53x
Quick Ratio (TTM)	16.01x	70.35x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.37	-0.05
52W Performance	140.1%	208.0%
YTD Performance	52.8%	208.0%
% from 52W High	-25.2%	-15.0%
% from 52W Low	154.6%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-4.1%	-2.2%
Earnings Yield (TTM)	-5.1%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EWTX research	View MANE research

Valuation

P/S Ratio

EWTX

0.00x

MANE

0.00x

EV/FCF

MANE

-42.29x

EWTX

-24.12x

Growth & revenue

Forward Revenue Growth

MANE

308.7%

EWTX

0.0%

Profitability & performance

Gross Margin

EWTX

0.0%

MANE

0.0%

ROE

MANE

-3549.0%

EWTX

-3901.0%

FCF Yield %

MANE

-2.2%

EWTX

-4.1%

52-Week Performance

MANE

208.0%

EWTX

140.1%

Detailed metrics comparison

EWTX

Edgewise Therapeutics Inc

MANE

Veradermics Inc

Market Cap

EWTX$3.90B

MANE$4.86B

Enterprise Value

EWTX$3.83B

MANE$4.54B

Price

EWTX$36.28

MANE$116.26

P/E Ratio

EWTXN/A

MANEN/A

P/S Ratio

EWTX0.00x

MANE0.00x

EV/Sales

EWTX0.00x

MANE0.00x

EV/EBITDA

EWTX0.00x

MANE0.00x

P/B Ratio

EWTX9.47x

MANE6.72x

P/FCF Ratio

EWTXN/A

MANEN/A

EV/FCF

EWTX-24.12x

MANE-42.29x

PEG Ratio

EWTXN/A

MANEN/A

Forward P/E (NTM)

EWTX19.86x

MANEN/A

Forward P/S (NTM)

EWTXN/A

MANEN/A

Revenue (TTM)

EWTX$0

MANE$0

Revenue Growth (YoY)

EWTXN/A

MANEN/A

Forward Rev Growth

EWTX0.0%

MANE308.7%

Gross Margin (TTM)

EWTX0.0%

MANE0.0%

Operating Margin (TTM)

EWTX0.0%

MANE0.0%

EBITDA Margin (TTM)

EWTX0.0%

MANE0.0%

Net Margin (TTM)

EWTX0.0%

MANE0.0%

FCF Margin (TTM)

EWTXN/A

MANEN/A

Net Income (TTM)

EWTX$-197M

MANE$-137M

FCF (TTM)

EWTX$-159M

MANE$-107M

EPS (TTM)

EWTX-$1.83

MANE-$3.39

ROE (TTM)

EWTX-3901.0%

MANE-3549.0%

ROA (TTM)

EWTX-3696.0%

MANE-3463.0%

ROIC (TTM)

EWTX-3901.0%

MANE-3549.0%

Cash

EWTX$72M

MANE$319M

Debt

EWTX$0

MANE$0

Net Cash/Debt

EWTX$72M

MANE$319M

Current Ratio (TTM)

EWTX16.24x

MANE70.53x

Quick Ratio (TTM)

EWTX16.01x

MANE70.35x

Debt/Equity (TTM)

EWTX0.00x

MANE0.00x

Debt/Assets (TTM)

EWTX0.0%

MANE0.0%

Interest Coverage (TTM)

EWTXN/A

MANEN/A

Net Debt/EBITDA (TTM)

EWTX0.00x

MANE0.00x

Beta

EWTX0.37

MANE-0.05

52W Performance

EWTX140.1%

MANE208.0%

YTD Performance

EWTX52.8%

MANE208.0%

% from 52W High

EWTX-25.2%

MANE-15.0%

% from 52W Low

EWTX154.6%

MANE263.3%

Asset Turnover (TTM)

EWTX0.00x

MANE0.00x

FCF Yield (TTM)

EWTX-4.1%

MANE-2.2%

Earnings Yield (TTM)

EWTX-5.1%

MANE-2.8%

Dividend Yield (TTM)

EWTXN/A

MANEN/A

Rule of 40

EWTX0.0

MANE0.0

EV/GP/RG

EWTXN/A

MANEN/A

Ticker research

View EWTX research View MANE research

Metric	EWTX Edgewise Therapeutics Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$3.90B	$4.86B
Enterprise Value	$3.83B	$4.54B
Price	$36.28	$116.26
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	9.47x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-24.12x	-42.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	19.86x	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	308.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-197M	$-137M
FCF (TTM)	$-159M	$-107M
EPS (TTM)	-$1.83	-$3.39
ROE (TTM)	-3901.0%	-3549.0%
ROA (TTM)	-3696.0%	-3463.0%
ROIC (TTM)	-3901.0%	-3549.0%
Financial Health
Cash	$72M	$319M
Debt	$0	$0
Net Cash/Debt	$72M	$319M
Current Ratio (TTM)	16.24x	70.53x
Quick Ratio (TTM)	16.01x	70.35x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.37	-0.05
52W Performance	140.1%	208.0%
YTD Performance	52.8%	208.0%
% from 52W High	-25.2%	-15.0%
% from 52W Low	154.6%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-4.1%	-2.2%
Earnings Yield (TTM)	-5.1%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EWTX research	View MANE research